Trial · NCT00039130
Adverse events427
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 427
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Blood disorder | Blood and lymphatic system disorders | Rituximab With High Intensity Chemotherapy | 2 | 105 | 2 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Rituximab With High Intensity Chemotherapy | 65 | 105 | 130 |
| other | Hemoglobin decreased | Blood and lymphatic system disorders | Rituximab With High Intensity Chemotherapy | 100 | 105 | 642 |
| other | Lymphatic disorder | Blood and lymphatic system disorders | Rituximab With High Intensity Chemotherapy | 1 | 105 | 1 |
| other | Transfusion: Platelets | Blood and lymphatic system disorders | Rituximab With High Intensity Chemotherapy | 18 | 105 | 41 |
| other | Transfusion: pRBCs | Blood and lymphatic system disorders | Rituximab With High Intensity Chemotherapy | 18 | 105 | 72 |
| other | Arrhythmia | Cardiac disorders | Rituximab With High Intensity Chemotherapy | 4 | 105 | 4 |
| other | Arrhythmia supraventricular | Cardiac disorders | Rituximab With High Intensity Chemotherapy | 4 | 105 | 5 |
| other | Atrial fibrillation | Cardiac disorders | Rituximab With High Intensity Chemotherapy | 2 | 105 | 2 |
| other | Cardiac disorder | Cardiac disorders | Rituximab With High Intensity Chemotherapy | 10 | 105 | 10 |
| other | Edema | Cardiac disorders | Rituximab With High Intensity Chemotherapy | 38 | 105 | 80 |
| other | Left ventricular failure | Cardiac disorders | Rituximab With High Intensity Chemotherapy | 3 | 105 | 5 |
| other | Myocardial ischemia | Cardiac disorders | Rituximab With High Intensity Chemotherapy | 1 | 105 | 1 |
| other | Pericardial effusion | Cardiac disorders | Rituximab With High Intensity Chemotherapy | 2 | 105 | 2 |
| other | Sinus bradycardia | Cardiac disorders | Rituximab With High Intensity Chemotherapy | 11 | 105 | 12 |
| other | Sinus tachycardia | Cardiac disorders | Rituximab With High Intensity Chemotherapy | 22 | 105 | 35 |
| other | Ear disorder | Ear and labyrinth disorders | Rituximab With High Intensity Chemotherapy | 4 | 105 | 4 |
| other | Ear pain | Ear and labyrinth disorders | Rituximab With High Intensity Chemotherapy | 3 | 105 | 3 |
| other | Tinnitus | Ear and labyrinth disorders | Rituximab With High Intensity Chemotherapy | 1 | 105 | 1 |
| other | Vertigo | Ear and labyrinth disorders | Rituximab With High Intensity Chemotherapy | 1 | 105 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00039130/events